Nuveen Asset Management’s Ovid Therapeutics OVID Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | $111K | Hold |
119,113
| – | – | ﹤0.01% | 3279 |
|
2024
Q3 | $141K | Hold |
119,113
| – | – | ﹤0.01% | 3279 |
|
2024
Q2 | $91.6K | Hold |
119,113
| – | – | ﹤0.01% | 3310 |
|
2024
Q1 | $363K | Buy |
119,113
+5,028
| +4% | +$15.3K | ﹤0.01% | 3057 |
|
2023
Q4 | $367K | Hold |
114,085
| – | – | ﹤0.01% | 3100 |
|
2023
Q3 | $438K | Hold |
114,085
| – | – | ﹤0.01% | 2887 |
|
2023
Q2 | $374K | Buy |
+114,085
| New | +$374K | ﹤0.01% | 2973 |
|
2021
Q2 | – | Sell |
-170,026
| Closed | -$683K | – | 3399 |
|
2021
Q1 | $683K | Sell |
170,026
-5,553
| -3% | -$22.3K | ﹤0.01% | 3014 |
|
2020
Q4 | $1.17M | Buy |
175,579
+4,897
| +3% | +$32.5K | ﹤0.01% | 2748 |
|
2020
Q3 | $980K | Sell |
170,682
-32,593
| -16% | -$187K | ﹤0.01% | 2704 |
|
2020
Q2 | $1.5M | Buy |
+203,275
| New | +$1.5M | ﹤0.01% | 2456 |
|